TearClear: TearClear picks out $22m series B - Global University Venturing
TearClear has raised $34.8m to date to fund an anti-preservative eye drop technology invented at University of Florida.
Read full article »
TearClear is an ophthalmic pharmaceutical company that develops and commercializes drugs for the treatment of eye disorders.
Read more